(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202506 | 202406 | % Var | 202506 | 202406 | % Var | 202503 | 202403 | % Var | |
| Sales | 15.66 | 17.47 | -10.36 | 15.66 | 17.47 | -10.36 | 65.28 | 70.30 | -7.14 |
| Other Income | 0.75 | 0.67 | 11.94 | 0.75 | 0.67 | 11.94 | 2.98 | 2.75 | 8.36 |
| PBIDT | 2.11 | 2.26 | -6.64 | 2.11 | 2.26 | -6.64 | 7.94 | 8.17 | -2.82 |
| Interest | 0.12 | 0.09 | 33.33 | 0.12 | 0.09 | 33.33 | 0.42 | 0.37 | 13.51 |
| PBDT | 1.99 | 2.17 | -8.29 | 1.99 | 2.17 | -8.29 | 7.52 | 7.80 | -3.59 |
| Depreciation | 0.39 | 0.32 | 21.88 | 0.39 | 0.32 | 21.88 | 1.31 | 1.30 | 0.77 |
| PBT | 1.60 | 1.85 | -13.51 | 1.60 | 1.85 | -13.51 | 6.21 | 6.50 | -4.46 |
| TAX | 0.42 | 0.48 | -12.50 | 0.42 | 0.48 | -12.50 | 1.23 | 1.64 | -25.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.52 | -0.02 | 2500.00 |
| PAT | 1.18 | 1.37 | -13.87 | 1.18 | 1.37 | -13.87 | 4.98 | 4.86 | 2.47 |
| Equity | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 |
| PBIDTM(%) | 13.47 | 12.94 | 4.15 | 13.47 | 12.94 | 4.15 | 12.16 | 11.62 | 4.66 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.15 |
| Dr. Reddys Lab | 1284.45 |
| Cipla | 1336.25 |
| Zydus Lifesciences | 938.15 |
| Lupin | 2251.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: